Last reviewed · How we verify

NCT06224101: Heart-SIMS1

Simulation Training For Invasive Cardiovascular Procedures

Completed NA Last updated 11 June 2024
What this trial tests

NA trial testing Simulation-based training in Coronary Artery Disease in 29 participants. Completed in 9 June 2024.

Timeline
15 December 2023
Primary endpoint
1 February 2024
9 June 2024

Quick facts

Lead sponsorUniversity of Coimbra
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment29
Start date15 December 2023
Primary completion1 February 2024
Estimated completion9 June 2024
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

University of Coimbra

Who can join

18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

28 sixth-year medical students will attend a theoretical learning session on coronary angiography. After they will be randomized in 2 groups: a conventional training (CT) group (n=14) and a simulation training (ST) group (n=14). CT group will visualize a video-recorded simulation procedure with duration of 20 minutes, while ST group will perform CA simulated training with SimulHeart in groups of two also for 20 minutes. Finally, after the training session, students' knowledge will be assessed through a theoretical multiple-choice exam and a practical evaluation in a catheterization laboratory using SimulHeart.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Simulation training for invasive cardiovascular procedures: the Heart-SIMS-1 randomized trial.
    Oliveira-Santos M, Guerreiro C, Lobo B, Marinho AV, et al · · 2026 · PMID 41826935 · DOI 10.1186/s12909-026-08831-6

Verify or expand the search:

Other trials of Simulation-based training

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other University of Coimbra trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06224101.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing